Search Results | Litt's Drug Eruption and Reaction Database

Nothing else can remotely compare to it.Patricia Wong, MD, Stanford University Medical Centre

Log in

Menu

Login

Home
About About
Alerts
Litt’s App
Contact Us
Help
Subscribe Subscribe
- Individual Subscription
- Institutional Subscription
Litt’s Feedback Survey

Drugs belonging to restart save

class – Direct-acting antiviral – 11 items found

show all
0–9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Elbasvir & Grazoprevir

Glecaprevir & Pibrentasvir

Ombitasvir/Paritaprevir/Ritonavir

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir

Sofosbuvir & Velpatasvir

Sofosbuvir/Velpatasvir/Voxilaprevir

Loading more results

No more results to show

Adverse reactions attributed to entire drug class 'Direct-acting antiviral'

Please login to view adverse reactions.

Gastrointestinal adverse reaction

(2022): Xie W+, Int J Clin Pharm Nov, Online ahead of print

(2019): Ridruejo E+, Nefrologia Jun, Epub ahead of print

Adverse effects / adverse reactions

(2019): Ridruejo E+, Nefrologia Jun, Epub ahead of print30%

Saved Searches Watched Drugs

Litt's app available free to subscribers

Search drug eruptions and reactions data anytime, anywhere

With full access to drug profiles, reactions and linked PubMed abstracts through your smart phone!

If you subscribe via your institution and do not have a personal login you will need to register on the website to create a login for the app.

Help
Terms & Conditions
Privacy
Disclaimer
Contact us

© 2025 Taylor & Francis Group, LLC. All Rights Reserved.